about
A novel semi-supervised methodology for extracting tumor type-specific MRS sources in human brain dataConvex non-negative matrix factorization for brain tumor delimitation from MRSI data.From raw data to data-analysis for magnetic resonance spectroscopy--the missing link: jMRUI2XML.Classification of brain tumours from MR spectra: the INTERPRET collaboration and its outcomes.MRS quality assessment in a multicentre study on MRS-based classification of brain tumours.SpectraClassifier 1.0: a user friendly, automated MRS-based classifier-development systemMultiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy.The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses.Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra.Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide TreatmentNon-negative matrix factorisation methods for the spectral decomposition of MRS data from human brain tumoursBrain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke.Strategies for annotation and curation of translational databases: the eTUMOUR projectComparison between neuroimaging classifications and histopathological diagnoses using an international multicenter brain tumor magnetic resonance imaging database.Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma.The effect of combining two echo times in automatic brain tumor classification by MRS.Robustness of equations that define molecular subtypes of glioblastoma tumors based on five transcripts measured by RT-PCRDevelopment of robust discriminant equations for assessing subtypes of glioblastoma biopsiesDevelopment of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies.Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas.Quality of clinical brain tumor MR spectra judged by humans and machine learning tools.Incremental Gaussian Discriminant Analysis based on Graybill and Deal weighted combination of estimators for brain tumour diagnosis.Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra.Multicentre evaluation of the INTERPRET decision support system 2.0 for brain tumour classification.A multi-centre, web-accessible and quality control-checked database of in vivo MR spectra of brain tumour patients.Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours.MRSI-based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis.Robust discrimination of glioblastomas from metastatic brain tumors on the basis of single-voxel (1)H MRS.Ranking of Brain Tumour Classifiers Using a Bayesian ApproachClassification of brain tumours from MR spectra: the INTERPRET collaboration and its outcomesUsefulness of Proton Magnetic Resonance Spectroscopy in the Clinical Management of Brain TumorsCancer metabolism in a snapshot: MRS(I)Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSIHealthAgents: distributed multi-agent brain tumor diagnosis and prognosisOn the relevance of automatically selected single-voxel MRS and multimodal MRI and MRSI features for brain tumour differentiationExtraction of artefactual MRS patterns from a large database using non-negative matrix factorizationAnti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological imagesEmbedding MRI information into MRSI data source extraction improves brain tumour delineation in animal models
P50
Q30000658-AF3EC5F0-DBA7-43CE-A842-DD779109C803Q30575323-883E9CFD-049A-439B-B583-C701A9CB7956Q31020370-0D08C494-1A38-48A3-A595-24AE711CAB9EQ31036955-82F26D71-A86C-471B-9AEA-D1AB632F8632Q31110466-716235E5-57BE-47D2-A77C-7216732C607DQ33534056-81C8B9C1-D05B-45CB-8D31-72AE670AD4FCQ33556108-742F3D1B-998A-4CA3-B3D7-752E3E912BF3Q33757835-657D71DA-81F6-4CB8-A4B2-8F3A4923FAB3Q33798119-D0125C6E-A3C8-4BD6-A061-415A474E3629Q33844943-0AB07342-0FA0-498F-924B-095916CA1EF6Q34188634-89E67A42-404E-403C-8CA1-E495C184498FQ36249269-D6FBEDC2-58CD-4E0C-815A-71B054AFA9E8Q36418095-990D2983-090D-4B90-8BA6-4F857C829F10Q38517977-0F3396B6-A47C-4F38-8817-22D2F2A5C43FQ38957729-C031B5C6-0D4D-462D-AA80-BB07448F7538Q40053123-B6FC4934-3331-4DC5-A84D-605A02A7F79BQ41620459-E4CAF5AF-8678-4043-A5B1-30374B7707E3Q42182048-B01057BF-6933-4CCC-9141-C45B24A753A2Q43126403-13AED173-C11C-4D5E-8184-0DCAA4E8C807Q43634719-8ACAB182-CD7F-4E5B-9CE7-008DF9EBA540Q45945104-824A854D-B2CB-4839-97B4-1988CA7D4773Q45962127-13D7A7C7-9847-4BE4-AF9F-25E5D6BB1538Q46190703-451EE217-8D8F-4A02-A863-E93549B7D65DQ48344360-0A6EAF93-9342-4E1F-B8E4-AF3B7AA41E01Q48503873-E0569D60-6763-446E-B4A9-A054215E4167Q48649757-6FB93830-D20F-456D-AB7A-F2F84ECB2928Q48650681-8C8EB212-9042-4F8A-83FC-9066341E3D03Q48875149-4BD94A73-4795-415E-8F15-98FD74108817Q50671051-A570BADE-ED12-4799-BDBD-001465B8412BQ51499135-3454F0F4-AF29-4F64-BBE5-A3B9212D38D6Q60536588-AA9AE595-715F-4EE8-9797-1C147803FFA9Q60536715-E5D031FE-EC3C-492D-A05B-B0448D600B27Q60547021-CF88F727-1DE2-415A-92CA-26E0153CA1A0Q60584192-0BA4B267-F1C8-438E-A0EB-DE2413B9D33AQ60584200-57B2AB30-54C4-4C1B-8CCF-6C41E5B7C2B3Q61734764-25CCC0E0-951B-47BC-8814-17274819B2E1Q62030334-65B4AB55-69AE-4667-A6F7-781B516B4230Q91631593-D7973DF1-87BF-4133-AB8C-7D2748F52BBDQ92569906-723B3F5A-8B20-4151-91C5-1FC324BBBFE8Q92638600-8C2B8117-73C5-4642-AF1F-AFC860323E8D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Margarida Julià-Sapé
@ast
Margarida Julià-Sapé
@en
Margarida Julià-Sapé
@es
Margarida Julià-Sapé
@nl
Margarida Julià-Sapé
@sl
type
label
Margarida Julià-Sapé
@ast
Margarida Julià-Sapé
@en
Margarida Julià-Sapé
@es
Margarida Julià-Sapé
@nl
Margarida Julià-Sapé
@sl
prefLabel
Margarida Julià-Sapé
@ast
Margarida Julià-Sapé
@en
Margarida Julià-Sapé
@es
Margarida Julià-Sapé
@nl
Margarida Julià-Sapé
@sl
P1053
A-4003-2009
P106
P1153
23392766000
P21
P2456
P31
P3829
P496
0000-0002-3316-9027